Sign in
4

Changes in Ownership

Lexeo Therapeutics, Inc. Filed Acc 0001209191-23-054910

Chief Technical Officer acquired 3,191 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

McCormac Paul · Chief Technical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-11-07 Conversion : show line 1 in the form +3,191 17,349 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-11-07 Conversion : show line 2 in the form Series B convertible preferred stock −29,061 0 D
Loading xslF345X05/doc4.xml…